X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (13) 13
humans (13) 13
index medicus (12) 12
male (11) 11
aged (10) 10
middle aged (8) 8
oncology (8) 8
adult (7) 7
further section (6) 6
aged, 80 and over (5) 5
cancer (5) 5
hematology (4) 4
prognosis (4) 4
follow-up studies (3) 3
retrospective studies (3) 3
surveys and questionnaires (3) 3
treatment outcome (3) 3
antineoplastic agents - therapeutic use (2) 2
anxiety - epidemiology (2) 2
architecture (2) 2
bibliography (2) 2
blood (2) 2
breast neoplasms - psychology (2) 2
cancer research (2) 2
chemotherapy (2) 2
chronic myeloid leukemia (2) 2
classification (2) 2
clinical study (2) 2
clinical trials (2) 2
comorbidity (2) 2
criticism and interpretation (2) 2
cytogenetic analysis (2) 2
emotions (2) 2
gemcitabine (2) 2
hematology, oncology and palliative medicine (2) 2
history (2) 2
immunohistochemistry (2) 2
internal medicine (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2) 2
lung neoplasms - genetics (2) 2
myeloproliferative neoplasms (2) 2
oncology, experimental (2) 2
pathology (2) 2
patient (2) 2
prevention (2) 2
primary myelofibrosis (2) 2
primary myelofibrosis - mortality (2) 2
questionnaires (2) 2
research (2) 2
respiratory system (2) 2
survival rate (2) 2
time factors (2) 2
validation (2) 2
waiting (2) 2
waiting room (2) 2
20th century (1) 1
7th edition (1) 1
a bibliografi bibliografier fagbibliografi forfatterbibliografi (1) 1
abnormal karyotype (1) 1
abridged index medicus (1) 1
activation (1) 1
acute myeloid leukemia (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adjuvant-cisplatin-evaluation (1) 1
advanced hematologic malignancies (1) 1
advanced hepatocellular-carcinoma (1) 1
advanced solid tumors (1) 1
affect (1) 1
age (1) 1
aged patients (1) 1
agnogenic myeloid metaplasia (1) 1
allmän idé- och lärdomshistoria: italien: medeltiden ca 476-1400 (1) 1
allogeneic transplantation (1) 1
alveolar cell-carcinoma (1) 1
anemia, hemolytic, autoimmune - drug therapy (1) 1
anemia, hemolytic, autoimmune - immunology (1) 1
anemia, hemolytic, autoimmune - surgery (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
animals (1) 1
anti-angiogenic treatment (1) 1
antibodies, anti-idiotypic - immunology (1) 1
antibodies, monoclonal, murine-derived - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
anxiety (1) 1
anxiety - etiology (1) 1
anxiety disorders - epidemiology (1) 1
anxiety disorders - etiology (1) 1
architecture exhibitions. environmental aspects (1) 1
architecture, modern (1) 1
architecture, modern exhibitions. 20th century (1) 1
architecture, western (1) 1
aristoteles (1) 1
aristotle (1) 1
aristotle. bibliography (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 3/2016, Volume 142, Issue 3, pp. 633 - 648
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1522 - 1522
Background The Revised- International Prognostic Index (R-IPI), the current standard prognostic tool for patients with diffuse large cell lymphoma (DLBCL),... 
Journal Article
Blood, ISSN 0006-4971, 11/2014, Volume 124, Issue 19, pp. 2930 - 2936
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 23, pp. 16437 - 16450
A number of pharmacogenetic studies have been carried out in non-small-cell lung cancer (NSCLC) to identify and characterize genes involved in chemotherapy... 
Nucleotidase | Response | Pharmacogenetics | Gemcitabine | Lung cancer
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1631 - 1631
Introduction: In the revised 2017 World Health Organization (WHO) classification of lymphoid neoplasms, high-grade B-cell lymphoma with C-MYC and BCL2 or BCL6... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 676 - 676
Abstract Diffuse large B-cell lymphoma (DLBCL) overexpressing MYC and BCL-2 have a poor outcome with standard therapies irrespective of the cell of origin... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1026 - 1026
Abstract Chronic idiopathic neutropenia (CIN) is a rare acquired hematological condition, defined by an absolute neutrophil count (ANCs) lower than 1.8 x103/µL... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3428 - 3428
Abstract The clinical presentation of autoimmune hemolytic anemia (AIHA) is greatly heterogeneous, from mild/compensated to life-threatening forms. The aim of... 
Journal Article
Clinical Management Issues, ISSN 1973-4832, 10/2015, Volume 5, Issue 6S, pp. 23 - 26
We report a case of excellent response to nilotinib in a 22 years old man with chronic myeloid leukemia in suboptimal response to imatinib. After diagnosis he... 
Nilotinib | Early switch | Chronic Myeloid Leukemia
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1346 - 1346
Abstract Autoimmune hemolytic anemia (AIHA) is a greatly heterogeneous condition both in terms of clinical presentation and response to treatment, usually... 
Journal Article
Journal Article
Journal Article
Clinical Laboratory, ISSN 1433-6510, 2014, Volume 60, Issue 11, pp. 1929 - 1932
Journal Article